{"id":27329,"date":"2012-03-16T13:00:07","date_gmt":"2012-03-16T17:00:07","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?post_type=voices&p=27329"},"modified":"2012-03-16T10:00:23","modified_gmt":"2012-03-16T14:00:23","slug":"helping-patients-understand-the-statins-controversy","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2012\/03\/16\/helping-patients-understand-the-statins-controversy\/","title":{"rendered":"Helping Patients Understand the Statins Controversy"},"content":{"rendered":"

After\u00a0the Topol op-ed in the New York Times last week<\/a>\u00a0I began to get a lot of inquiries about the safety of statins. At the beginning of his piece he emphasizes that our use of statins could cause a “sharp increase in the incidence of Type 2 diabetes.” At the end, he states emphatically that “the problem of statin-induced diabetes cannot be underplayed.” Many patients reading these words were worried about their decision to take statins. I decided to write a missive to patients to help them sort through all the information about statins– and to help them in their decisions about treatment. I told them that there were five things that they needed to know:<\/p>\n

    \n
  1. It is your decision.<\/li>\n
  2. Statins reduce risk.<\/li>\n
  3. Statins have risks.<\/li>\n
  4. Your risks matter.<\/li>\n
  5. Minimize your statin risk.<\/li>\n<\/ol>\n

    You may find it useful for your patients. The title is\u00a0Five Things You Need to Know When Deciding on a Cholesterol Lowering Drug<\/a>. Feel free to share your thoughts about it \u2013 or to use it if you think it may be helpful to you.<\/p>\n","protected":false},"excerpt":{"rendered":"

    After\u00a0the Topol op-ed in the New York Times last week\u00a0I began to get a lot of inquiries about the safety of statins. At the beginning of his piece he emphasizes that our use of statins could cause a “sharp increase in the incidence of Type 2 diabetes.” At the end, he states emphatically that “the […]<\/p>\n","protected":false},"author":211,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,7],"tags":[329,200,584],"class_list":["post-27329","post","type-post","status-publish","format-standard","hentry","category-general","category-prevention","tag-cardiovascular-risk","tag-diabetes","tag-statins"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/27329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/211"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=27329"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/27329\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=27329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=27329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=27329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}